Menu Back toSession-0505-Post-Marketing-Safety-Surveillance

The 7th DIA China Annual Meeting


Session 0505 Post Marketing Safety Surveillance

Session Chair(s)

Ivy  Wang

Ivy Wang

  • Associate Director, Safety Surveillance & Risk Management
  • Pfizer, China

Evidence Triggered and Evidence Based - Thinking of Postmarking Drug Safety Issues (CN&EN)

Speaker(s)

Dayou  WANG

Evidence Triggered and Evidence Based - Thinking of Postmarking Drug Safety Issues (CN&EN)

Dayou WANG

  • Huashan Hospital, Fudan University, China
Howe  Li

Signal Detection during Post-marketing Surveillance(CN&EN)

Howe Li

  • CMO
  • Tigermed, China

Contact us

For exhibition, advertising and hosting inquiry, please contact:
Jean XU: jxu@kellencompany.com, or Sofie Peeters: speeters@kellencompany.com
Tel: +86 10 5923 1096

For general inquiry, please contact DIA China office:
dia@diachina.org
Tel: +86 10 5704 2650